October 01, 2015
Wellesley, Mass., October 1, 2015 – Cell-based assays that assess cellular immunity and multiple cytokine levels have advanced rapidly in the past decade. BCC Research reveals in its new report that these and other technological advances in cellular research are keying impressive market growth.
Cell expansion technology has emerged as a promising therapeutic solution for brain and spinal cord injuries, neurodegeneration, cardiovascular disorders, blood cell formation, diabetes, and a myriad of other conditions. It is also used to diagnose some types of tumors, and used in the production of regenerative medicines. The cell expansion market in this report considers two cell types: animal cells and human cells. The report also analyzes the three major categories that comprise the cell expansion product market: consumables, instruments and cell expansion supporting equipment.
The global cell expansion market totaled nearly $8.5 billion in 2014, and is expected to reach $22 billion by 2020, reflecting a five-year (2015-2020) CAGR of 17.8%. As the larger segment of the two cell types, the human cell market totaled nearly $6.4 billion in 2014, and should grow to almost $17.3 billion by 2020. In the end-users segment of the market, hospital and diagnostic centers should remain the leading segment through 2020, more than doubling its 2014 value to $13 billion by 2020. Consumables, the largest revenue-generating product segment, reached nearly $6.2 billion in 2014 and is expected to almost triple in value through 2020. The instruments product segment should demonstrate the highest growth rate at 20.7% over the analysis period, due to the increasing use of cell culture-specific instruments such as bioreactors and automated cell expansion systems.
The geographical segmentation of the cell expansion market includes North America, Europe, Asia-Pacific and ROW. North America is the largest revenue-generating region, courtesy of a high growth rate attributable to that continent’s increasing research on advanced biologics and bio-similar drugs. Europe is the second largest market, thanks to its large number of bio-pharmaceutical clinical research organizations and diagnostic centers. In the Asia-Pacific region, the market is projected to reach a five-year CAGR of 22.2%, the highest CAGR among the geographic segments.
“Factors driving the growth of the cell expansion market are technological advancements in cell expansion, the increase in chronic disease and the increasing number of GMP-certified cell therapy facilities,” says BCC Research analyst Yojana Jeevane. “For example, the assays for the measurement of cytotoxic T cells against infected targets in humans and animals have improved due to the inclusion of tests such as the enzyme-linked immunosorbent spot test and the fluorescence cell sorting test. Various market players such as Miltenyi Biotec and EMD Millipore have developed novel assays that utilize cell expansion technologies to measure cytokine levels required in T cell production.”
Cell Expansion Technologies and Global Markets (BIO144A) examines cell expansion as categorized by two major types, animal cells and human cells. The report includes analysis of applications such as clinical diagnostics, drug discovery and development, and regenerative medicine. Market dynamics, growth drivers, inhibitors, trends and revenue through 2020 also are provided.
Editors and reporters who wish to speak with the analyst should contact Steven Cumming at firstname.lastname@example.org.
Cell Expansion Technologies and Global Markets( BIO144A )
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email email@example.com or visit www.bccresearch.com/media to request access to our library of market research.